A citation-based method for searching scientific literature

Jungmin Choi, Aranzazu Manzano, Weilai Dong, Stefania Bellone, Elena Bonazzoli, Luca Zammataro, Xiaotong Yao, Aditya Deshpande, Samir Zaidi, Adele Guglielmi, Barbara Gnutti, Nupur Nagarkatti, Joan R Tymon-Rosario, Justin Harold, Dennis Mauricio, Burak Zeybek, Gulden Menderes, Gary Altwerger, Kyungjo Jeong, Siming Zhao, Natalia Buza, Pei Hui, Antonella Ravaggi, Eliana Bignotti, Chiara Romani, Paola Todeschini, Laura Zanotti, Franco Odicino, Sergio Pecorelli, Laura Ardighieri, Kaya Bilguvar, Charles M Quick, Dan-Arin Silasi, Gloria S Huang, Vaagn Andikyan, Mitchell Clark, Elena Ratner, Masoud Azodi, Marcin Imielinski, Peter E Schwartz, Ludmil B Alexandrov, Richard P Lifton, Joseph Schlessinger, Alessandro D Santin. Proc Natl Acad Sci U S A 2021
Times Cited: 22







List of co-cited articles
95 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Integrative genomic and transcriptomic analysis of leiomyosarcoma.
Priya Chudasama, Sadaf S Mughal, Mathijs A Sanders, Daniel Hübschmann, Inn Chung, Katharina I Deeg, Siao-Han Wong, Sophie Rabe, Mario Hlevnjak, Marc Zapatka,[...]. Nat Commun 2018
135
50

Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing.
Martee L Hensley, Shweta S Chavan, David B Solit, Rajmohan Murali, Robert Soslow, Sarah Chiang, Achim A Jungbluth, Chaitanya Bandlamudi, Preethi Srinivasan, William D Tap,[...]. Clin Cancer Res 2020
31
36

Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways.
Tine Cuppens, Matthieu Moisse, Jeroen Depreeuw, Daniela Annibali, Eva Colas, Antonio Gil-Moreno, Jutta Huvila, Olli Carpén, Michal Zikán, Xavier Matias-Guiu,[...]. Int J Cancer 2018
43
36

Soft Tissue and Uterine Leiomyosarcoma.
Suzanne George, César Serrano, Martee L Hensley, Isabelle Ray-Coquard. J Clin Oncol 2018
97
27

Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12.
Netta Mäkinen, Mervi Aavikko, Tuomas Heikkinen, Minna Taipale, Jussi Taipale, Riitta Koivisto-Korander, Ralf Bützow, Pia Vahteristo. PLoS Genet 2016
68
27

Clinically Relevant Molecular Subtypes in Leiomyosarcoma.
Xiangqian Guo, Vickie Y Jo, Anne M Mills, Shirley X Zhu, Cheng-Han Lee, Inigo Espinosa, Marisa R Nucci, Sushama Varma, Erna Forgó, Trevor Hastie,[...]. Clin Cancer Res 2015
94
22

Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.
Martee L Hensley, John A Blessing, Koen Degeest, Ovadia Abulafia, Peter G Rose, Howard D Homesley. Gynecol Oncol 2008
170
18

Genomic Database Analysis of Uterine Leiomyosarcoma Mutational Profile.
Annalisa Astolfi, Margherita Nannini, Valentina Indio, Angela Schipani, Alessandro Rizzo, Anna Myriam Perrone, Pierandrea De Iaco, Maria Giulia Pirini, Antonio De Leo, Milena Urbini,[...]. Cancers (Basel) 2020
23
18

BRCA1/2 Functional Loss Defines a Targetable Subset in Leiomyosarcoma.
Nathan D Seligson, Esko A Kautto, Edward N Passen, Colin Stets, Amanda E Toland, Sherri Z Millis, Christian F Meyer, John L Hays, James L Chen. Oncologist 2019
27
18

Uterine Leiomyosarcoma.
Ingolf Juhasz-Böss, Lena Gabriel, Rainer M Bohle, Lars C Horn, Erich-Franz Solomayer, Georg-Peter Breitbach. Oncol Res Treat 2018
18
16

Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
Kelly D Gonzalez, Katie A Noltner, Carolyn H Buzin, Dongqing Gu, Cindy Y Wen-Fong, Vu Q Nguyen, Jennifer H Han, Katrina Lowstuter, Jeffrey Longmate, Steve S Sommer,[...]. J Clin Oncol 2009
365
13

Novel PLAG1 Gene Rearrangement Distinguishes a Subset of Uterine Myxoid Leiomyosarcoma From Other Uterine Myxoid Mesenchymal Tumors.
Javier A Arias-Stella, Ryma Benayed, Esther Oliva, Robert H Young, Lien N Hoang, Cheng-Han Lee, Achim A Jungbluth, Denise Frosina, Robert A Soslow, Cristina R Antonescu,[...]. Am J Surg Pathol 2019
30
13

Targeted next-generation sequencing of cancer genes identified frequent TP53 and ATRX mutations in leiomyosarcoma.
Ching-Yao Yang, Jau-Yu Liau, Wei-Ju Huang, Yu-Ting Chang, Ming-Chu Chang, Jen-Chieh Lee, Jia-Huei Tsai, Yi-Ning Su, Chia-Cheng Hung, Yung-Ming Jeng. Am J Transl Res 2015
38
13

Treatment with epigenetic agents profoundly inhibits tumor growth in leiomyosarcoma.
Cynthia De Carvalho Fischer, Yue Hu, Michael Morreale, Wan Ying Lin, Akhil Wali, Maya Thakar, Enusha Karunasena, Rupashree Sen, Yi Cai, Lauren Murphy,[...]. Oncotarget 2018
11
27


Oncogenic Gene-Expression Programs in Leiomyosarcoma and Characterization of Conventional, Inflammatory, and Uterogenic Subtypes.
Matthew L Hemming, Changyu Fan, Chandrajit P Raut, George D Demetri, Scott A Armstrong, Ewa Sicinska, Suzanne George. Mol Cancer Res 2020
12
25

The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.
Aaron McKenna, Matthew Hanna, Eric Banks, Andrey Sivachenko, Kristian Cibulskis, Andrew Kernytsky, Kiran Garimella, David Altshuler, Stacey Gabriel, Mark Daly,[...]. Genome Res 2010
13

Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study.
Jean-Yves Blay, Patrick Schöffski, Sebastian Bauer, Anders Krarup-Hansen, Charlotte Benson, David R D'Adamo, Yan Jia, Robert G Maki. Br J Cancer 2019
15
20

Uterine leiomyosarcoma: A review of the literature and update on management options.
Maureen E Roberts, Jason T Aynardi, Christina S Chu. Gynecol Oncol 2018
62
13

Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database study.
Brandon-Luke L Seagle, Janelle Sobecki-Rausch, Anna E Strohl, Arunima Shilpi, Anne Grace, Shohreh Shahabi. Gynecol Oncol 2017
83
13

Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas.
Inga-Marie Schaefer, Meijun Z Lundberg, Elizabeth G Demicco, Joanna Przybyl, Magdalena Matusiak, Frédéric Chibon, Davis R Ingram, Jason L Hornick, Wei-Lien Wang, Sebastian Bauer,[...]. Cancer 2021
6
50

Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.
Netta Mäkinen, Kati Kämpjärvi, Norma Frizzell, Ralf Bützow, Pia Vahteristo. Mol Cancer 2017
45
13

Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway Genes.
Evan Rosenbaum, Philip Jonsson, Kenneth Seier, Li-Xuan Qin, Ping Chi, Mark Dickson, Mrinal Gounder, Ciara Kelly, Mary L Keohan, Benjamin Nacev,[...]. JCO Precis Oncol 2020
11
27

Uterine sarcomas: a review.
Emanuela D'Angelo, Jaime Prat. Gynecol Oncol 2010
467
13

Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial.
Beatrice Seddon, Sandra J Strauss, Jeremy Whelan, Michael Leahy, Penella J Woll, Fiona Cowie, Christian Rothermundt, Zoe Wood, Charlotte Benson, Nasim Ali,[...]. Lancet Oncol 2017
242
13

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.
Winette T A van der Graaf, Jean-Yves Blay, Sant P Chawla, Dong-Wan Kim, Binh Bui-Nguyen, Paolo G Casali, Patrick Schöffski, Massimo Aglietta, Arthur P Staddon, Yasuo Beppu,[...]. Lancet 2012
13

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.
Kathleen N Moore, Angeles Alvarez Secord, Melissa A Geller, David Scott Miller, Noelle Cloven, Gini F Fleming, Andrea E Wahner Hendrickson, Masoud Azodi, Paul DiSilvestro, Amit M Oza,[...]. Lancet Oncol 2019
246
13

Tumour lineage shapes BRCA-mediated phenotypes.
Philip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, Preethi Srinivasan, Shweta S Chavan, Noah D Friedman, Ezra Y Rosen, Allison L Richards, Nancy Bouvier, S Duygu Selcuklu,[...]. Nature 2019
198
13

Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss.
Douglas I Lin, Amanda Hemmerich, Claire Edgerly, Daniel Duncan, Eric A Severson, Richard S P Huang, Shakti H Ramkissoon, Yamicia D Connor, Meghan Shea, Jonathan L Hecht,[...]. Gynecol Oncol 2020
23
9

Integrated genomic characterization of endometrial carcinoma.
Cyriac Kandoth, Nikolaus Schultz, Andrew D Cherniack, Rehan Akbani, Yuexin Liu, Hui Shen, A Gordon Robertson, Itai Pashtan, Ronglai Shen, Christopher C Benz,[...]. Nature 2013
9

Uterine mesenchymal tumours: recent advances.
Amir Momeni-Boroujeni, Sarah Chiang. Histopathology 2020
29
9

Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition.
Siming Zhao, Stefania Bellone, Salvatore Lopez, Durga Thakral, Carlton Schwab, Diana P English, Jonathan Black, Emiliano Cocco, Jungmin Choi, Luca Zammataro,[...]. Proc Natl Acad Sci U S A 2016
126
9

Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer.
K Kämpjärvi, N Mäkinen, O Kilpivaara, J Arola, H-R Heinonen, J Böhm, O Abdel-Wahab, H J Lehtonen, L M Pelttari, M Mehine,[...]. Br J Cancer 2012
85
9

Genomics of uterine leiomyomas: insights from high-throughput sequencing.
Miika Mehine, Netta Mäkinen, Hanna-Riikka Heinonen, Lauri A Aaltonen, Pia Vahteristo. Fertil Steril 2014
115
9

Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.
Ian P M Tomlinson, N Afrina Alam, Andrew J Rowan, Ella Barclay, Emma E M Jaeger, David Kelsell, Irene Leigh, Patricia Gorman, Hanan Lamlum, Shamima Rahman,[...]. Nat Genet 2002
9

Identification of potential therapeutic targets by molecular profiling of 628 cases of uterine serous carcinoma.
Nathaniel L Jones, Joanne Xiu, Sandeep K Reddy, William M Burke, Ana I Tergas, Jason D Wright, June Y Hou. Gynecol Oncol 2015
19
10

Myxoid Leiomyosarcoma of the Uterus: A Clinicopathologic Analysis of 30 Cases and Review of the Literature With Reappraisal of Its Distinction From Other Uterine Myxoid Mesenchymal Neoplasms.
Carlos Parra-Herran, John K Schoolmeester, Liping Yuan, Paola Dal Cin, Christopher D M Fletcher, Bradley J Quade, Marisa R Nucci. Am J Surg Pathol 2016
56
9

Genomic, Epigenomic, and Transcriptomic Profiling towards Identifying Omics Features and Specific Biomarkers That Distinguish Uterine Leiomyosarcoma and Leiomyoma at Molecular Levels.
Tomoko Miyata, Kenzo Sonoda, Junko Tomikawa, Chiharu Tayama, Kohji Okamura, Kayoko Maehara, Hiroaki Kobayashi, Norio Wake, Kiyoko Kato, Kenichiro Hata,[...]. Sarcoma 2015
21
9

Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling.
A H Beck, C-H Lee, D M Witten, B C Gleason, B Edris, I Espinosa, S Zhu, R Li, K D Montgomery, R J Marinelli,[...]. Oncogene 2010
99
9

The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
Mohamad Farid, Whee Sze Ong, Mann Hong Tan, Leon Siang Shen Foo, Yong Kuei Lim, Whay Kuang Chia, Lay Tin Soh, Donald Poon, Marcus Jin Fu Lee, Zhen Chong Ho,[...]. Am J Clin Oncol 2013
30
9

The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research.
Corrie A Painter, Esha Jain, Brett N Tomson, Michael Dunphy, Rachel E Stoddard, Beena S Thomas, Alyssa L Damon, Shahrayz Shah, Dewey Kim, Jorge Gómez Tejeda Zañudo,[...]. Nat Med 2020
95
9

B cells are associated with survival and immunotherapy response in sarcoma.
Florent Petitprez, Aurélien de Reyniès, Emily Z Keung, Tom Wei-Wu Chen, Cheng-Ming Sun, Julien Calderaro, Yung-Ming Jeng, Li-Ping Hsiao, Laetitia Lacroix, Antoine Bougoüin,[...]. Nature 2020
690
9

Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial.
Breelyn A Wilky, Matteo M Trucco, Ty K Subhawong, Vaia Florou, Wungki Park, Deukwoo Kwon, Eric D Wieder, Despina Kolonias, Andrew E Rosenberg, Darcy A Kerr,[...]. Lancet Oncol 2019
178
9



Uterine leiomyomata with t(10;17) disrupt the histone acetyltransferase MORF.
Steven D P Moore, Steven R Herrick, Tan A Ince, Michael S Kleinman, Paola Dal Cin, Cynthia C Morton, Bradley J Quade. Cancer Res 2004
74
9

Oncologic and Reproductive Outcomes of Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: A Single Center Retrospective Study of 67 Cases.
Lanqing Huo, Dan Wang, Wenze Wang, Dongyan Cao, Jiaxin Yang, Ming Wu, Junjun Yang, Yang Xiang. Front Oncol 2020
9
22

Leiomyoma with KAT6B-KANSL1 fusion: case report of a rapidly enlarging uterine mass in a postmenopausal woman.
Alessandra J Ainsworth, Nooshin K Dashti, Taofic Mounajjed, Karen J Fritchie, Jaime Davila, Rohini Mopuri, Rory A Jackson, Kevin C Halling, Jamie N Bakkum-Gamez, J Kenneth Schoolmeester. Diagn Pathol 2019
5
40

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
Aravind Subramanian, Pablo Tamayo, Vamsi K Mootha, Sayan Mukherjee, Benjamin L Ebert, Michael A Gillette, Amanda Paulovich, Scott L Pomeroy, Todd R Golub, Eric S Lander,[...]. Proc Natl Acad Sci U S A 2005
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.